Project Number 5R01AG061894-03 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 9. Immunity and Inflammation b. Microglia Category F. Research Resources 6. Disease Models e. iPS Cells Researcher and Organization Principal Investigator NOGGLE, SCOTT ALLEN Principal Investigator First Name SCOTT ALLEN Principal Investigator Last Name NOGGLE Awardee Organization NEW YORK STEM CELL FOUNDATION Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-516: Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed) FY Overall Cost $877,246 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C
